The association between biomarker-based exposure estimates for phthalates and demographic factors in a human reference population.

Population-based estimates of environmental exposures using biomarkers can be difficult to obtain for a variety of reasons, including problems with limits of detection, undersampling of key strata, time between exposure and sampling, variation across individuals, variation within individuals, and the ability to find and interpret a given biomarker. In this article, we apply statistical likelihoods, weighted sampling, and regression methods for censored data to the analysis of biomarker data. Urinary metabolites for seven phthalates, reported by Blount et al., are analyzed using these methods. In the case of the phthalates data, we assumed the underlying model to be a log-normal distribution with the mean of the distribution defined as a function of a number of demographic variables that might affect phthalate levels in individuals. Included as demographic variables were age, sex, ethnicity, residency, family income, and education level. We conducted two analyses: an unweighted analysis where phthalate distributions were estimated with changes in the means of these distributions as a function of demographic variables, and a weighted prediction for the general population in which weights were assigned for a subset of the population depending on the frequency of their demographic variables in the general U.S. population. We used statistical tests to determine whether any of the demographic variables affected mean phthalate levels. Individuals with only a high school education had higher levels of di-n-butyl phthalate than individuals with education beyond high school. Subjects who had family income less than $1,500 in the month before sampling and/or only high school education had higher levels of n-butyl benzyl phthalate levels than other groupings. Di(2-ethylhexyl) phthalate was higher in males and/or in urban populations and/or in people who had family income less than $1,500 per month. Our findings suggest that there may be significant demographic variations in exposure and/or metabolism of phthalates and that health-risk assessments for phthalate exposure in humans should consider different potential risk groups.

[1]  L L Needham,et al.  Human exposure estimates for phthalates. , 2000, Environmental health perspectives.

[2]  L L Needham,et al.  Levels of seven urinary phthalate metabolites in a human reference population. , 2000, Environmental health perspectives.

[3]  Andrew M. Wilson,et al.  Fitting Second‐Order Finite Mixture Models to Data with Many Censored Values Using Maximum Likelihood Estimation , 2000, Risk analysis : an official publication of the Society for Risk Analysis.

[4]  J. Lindsey,et al.  Generalized Nonlinear Models for Pharmacokinetic Data , 2000, Biometrics.

[5]  M. Chagnon,et al.  Metabolism of n-butyl benzyl phthalate in the female Wistar rat. Identification of new metabolites. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  L. Gray,et al.  Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproduc , 1999, Toxicology and industrial health.

[7]  C. A. Harris,et al.  The estrogenic activity of phthalate esters in vitro. , 1997, Environmental health perspectives.

[8]  M. Ema,et al.  Developmental toxicity of mono-n-benzyl phthalate, one of the major metabolites of the plasticizer n-butyl benzyl phthalate, in rats. , 1996, Toxicology letters.

[9]  F. Marriott,et al.  Evaluation of censored contamination data. , 1995, Food additives and contaminants.

[10]  J. Pirkle,et al.  Using biological monitoring to assess human exposure to priority toxicants. , 1995, Environmental health perspectives.

[11]  M. Ema,et al.  Teratogenic phase specificity of butyl benzyl phthalate in rats. , 1993, Toxicology.

[12]  J. Heindel,et al.  Phthalate ester effects on rat Sertoli cell function in vitro: effects of phthalate side chain and age of animal. , 1992, Toxicology and applied pharmacology.

[13]  T. Gray,et al.  Effect of some phthalate esters and other testicular toxins on primary cultures of testicular cells. , 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  S. Oishi,et al.  Testicular atrophy induced by di-2-ethylhexyl phthalate: effect of zinc supplement. , 1983, Toxicology and applied pharmacology.

[15]  P. Foster,et al.  The morphological development of di‐n‐pentyl phthalate induced testicular atrophy in the rat , 1983, The Journal of pathology.

[16]  P. Boulanger,et al.  Ultraviolet absorption, aqueous solubility, and octanol-water partition for several phthalates , 1983, Bulletin of environmental contamination and toxicology.

[17]  J. F. Douglas,et al.  Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. , 1982, Environmental health perspectives.

[18]  W. Kluwe,et al.  Overview of phthalate ester pharmacokinetics in mammalian species. , 1982, Environmental health perspectives.

[19]  P. Albro,et al.  Toxic potential of the plasticizer Di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. , 1982, Environmental health perspectives.

[20]  Oishi Shinshi,et al.  Effects of monoesters of o-phthalic acid on serum lipid composition of rats , 1982 .

[21]  O. G. Nilsen,et al.  Phthalate esters I: effects on cytochrome P-450 mediated metabolism in rat liver and lung, serum enzymatic activities and serum protein levels , 1982, Archives of Toxicology.

[22]  P. Foster,et al.  Study of the testicular effects and changes in zinc excretion produced by some n-alkyl phthalates in the rat. , 1980, Toxicology and applied pharmacology.

[23]  K. Shiota,et al.  Embryotoxic effects of di-2-ethylhexyl phthalate (DEHP) and di-n-buty phthalate (DBP) in mice. , 1980, Environmental research.

[24]  J. Reddy,et al.  Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens , 1980, Nature.

[25]  H. Maxon,et al.  A statistical method for determining normal ranges from laboratory data including values below the minimum detectable value. , 1979, Clinical chemistry.

[26]  A. Aitio,et al.  Effect of phthalate esters on drug metabolizing enzyme activities in rat liver. , 1978, Archives internationales de pharmacodynamie et de therapie.

[27]  J K Reddy,et al.  Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. , 1978, Toxicology and applied pharmacology.

[28]  T Yamaha,et al.  Biochemical studies on phthalic esters. III. Metabolism of dibutyl phthalate (DBP) in animals. , 1978, Toxicology.

[29]  K. Pittman,et al.  Mirex kinetics in the rhesus monkey. II. Pharmacokinetic model. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[30]  M. Rao,et al.  Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice. , 1976, Life sciences.

[31]  H. Matthews,et al.  The distribution and excretion of 2,4,5,2',5'-pentachlorobiphenyl in the rat. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[32]  A. Tanaka,et al.  Biochemical studies on phthalic esters I. Elimination, distribution and metabolism of di-(2-ethylhexyl)phthalate in rats. , 1975, Toxicology.

[33]  D. T. Williams,et al.  The retention, distribution, excretion, and metabolism of dibutyl phthalate-7-14 C in the rat. , 1975, Journal of agricultural and food chemistry.

[34]  P. Albro,et al.  Identification of the metabolites of simple phthalate diesters in rat urine. , 1974, Journal of chromatography.

[35]  D. T. Williams,et al.  Retention, excretion and metabolism of Di-(2-ethylhexyl) phthalate administered orally to the rat , 1974, Bulletin of environmental contamination and toxicology.

[36]  H. Bratt,et al.  The absorption, metabolism and tissue distribution of di(2-ethylhexyl)phthalate in rats. , 1974, Toxicology.

[37]  J. Autian.  Toxicity and health threats of phthalate esters: review of the literature. , 1973, Environmental health perspectives.

[38]  D. E. Carter,et al.  Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat. , 1986, Journal of toxicology and environmental health.

[39]  S. Oishi,et al.  Testicular atrophy induced by di-2-ethylhexyl phthalate : Effect of zinc supplement , 1984 .

[40]  D. G. Walters,et al.  Differences in urinary metabolic profile from di-n-butyl phthalate-treated rats and hamsters. A possible explanation for species differences in susceptibility to testicular atrophy. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[41]  S. Oishi,et al.  Effects of monoesters of O-phthalic acid on serum lipid composition of rats. , 1982, Toxicology letters.

[42]  H. Greim,et al.  Enhanced fecal excretion of mirex in rhesus monkeys by 5% mineral oil in the diet. , 1981, Drug and chemical toxicology.

[43]  D. Commerce.  Statistical abstract of the United States , 1978 .

[44]  J. Tobin.  Estimation of Relationships for Limited Dependent Variables , 1958 .